NeuroDex research library

Alzheimer’s disease: blood biomarker library

Plasma p-Tau217, Aβ42/40, GFAP and NfL have changed how Alzheimer’s pathology is detected. Drug programs still need to know more: which patients carry co-pathology, whether a drug changes neuronal biology, and how to pick a marker for each decision. These articles cover diagnosis, trial design and mechanism-of-action readouts from blood.

Start here

Biomarkers in drug development

Assays

NeuroDex research

Field news